Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    Open Studies | "Alopecia"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Alopecia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Study of Secukinumab for the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Secukinumab;   Drug: Placebo
2 Recruiting Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Apremilast;   Drug: Placebo
3 Recruiting A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Tralokinumab;   Drug: Placebo
4 Recruiting Topical Garlic Concentrate for Alopecia Areata in Children
Condition: Alopecia Areata
Intervention: Drug: garlic concentrate
5 Recruiting Excimer Light for Alopecia Areata
Condition: Alopecia Areata
Intervention: Procedure: UVB excimer light
6 Recruiting Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)
Condition: Alopecia
Interventions: Drug: CG 428 cutaneous solution;   Drug: Placebo cutaneous solution
7 Recruiting Intralesional Steroids in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Intralesional Triamcinolone 2.5 mg/ml;   Drug: Intralesional Triamcinolone 5 mg/ml;   Drug: Intralesional Triamcinolone 10 mg/ml;   Drug: Intralesional Saline
8 Not yet recruiting Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment
Condition: Androgenetic Alopecia
Interventions: Device: Autologous Platelet Rich Plasma;   Device: Saline solution injection
9 Recruiting Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Condition: Alopecia
Interventions: Drug: setipiprant;   Drug: placebo;   Drug: finasteride
10 Recruiting "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"
Condition: Chemotherapy-induced Alopecia
Intervention: Behavioral: Semi-structured interviews
11 Not yet recruiting Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: PF-06651600;   Drug: PF-06700841;   Drug: Placebo
12 Recruiting LEO 124249 Ointment in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: LEO 124249;   Other: Vehicle
13 Not yet recruiting Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: SHAPE Gel
14 Not yet recruiting Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia
Condition: Frontal Fibrosing Alopecia
Intervention: Other: Corticosteroid/Saline
15 Recruiting TREg Activation in the Treatment of the PELADE (Alopecia Areata)
Condition: Alopecia Areata
Interventions: Drug: IL2;   Drug: placebo
16 Recruiting Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention: Drug: Tofacitinib ointment
17 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
18 Recruiting Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
Condition: Alopecia Areata
Intervention: Other: MEXIS/M6S Patent - lotion against alopecia
19 Recruiting Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
Conditions: Alopecia;   Alopecia, Androgenetic;   Baldness
Intervention: Drug: Bimatoprost
20 Recruiting PAI-1 Expression in Non-scarring Hair Loss
Conditions: Androgenetic Alopecia;   Telogen Effluvium;   Alopecia Areata
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.